Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives

por Myers, Meagan B
Publicado 2016

Variation in organ‐specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas

por Parsons, Barbara L., McKim, Karen L., Myers, Meagan B.
Publicado 2017

Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids

por Banda, Malathi, McKim, Karen L., Myers, Meagan B., Inoue, Masahiro, Parsons, Barbara L.
Publicado 2020

Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology

por Myers, Meagan B., McKim, Karen L., Banda, Malathi, George, Nysia I., Parsons, Barbara L.
Publicado 2019

Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk

por Harris, Kelly L., Myers, Meagan B., McKim, Karen L., Elespuru, Rosalie K., Parsons, Barbara L.
Publicado 2019

Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas()()

por Myers, Meagan B., Banda, Malathi, McKim, Karen L., Wang, Yiying, Powell, Michael J., Parsons, Barbara L.
Publicado 2016

Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq

por Harris, Kelly L., Walia, Vijay, Gong, Binsheng, McKim, Karen L., Myers, Meagan B., Xu, Joshua, Parsons, Barbara L.
Publicado 2020

Fixation and Spread of Somatic Mutations in Adult Human Colonic Epithelium

por Nicholson, Anna M., Olpe, Cora, Hoyle, Alice, Thorsen, Ann-Sofie, Rus, Teja, Colombé, Mathilde, Brunton-Sim, Roxanne, Kemp, Richard, Marks, Kate, Quirke, Phil, Malhotra, Shalini, ten Hoopen, Rogier, Ibrahim, Ashraf, Lindskog, Cecilia, Myers, Meagan B., Parsons, Barbara, Tavaré, Simon, Wilkinson, Mark, Morrissey, Edward, Winton, Douglas J.
Publicado 2018